These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34985401)

  • 1. The impact of visual memory impairment on Victoria Symptom Validity Test performance: A known-groups analysis.
    Stocks JK; Shields AN; DeBoer AB; Cerny BM; Ogram Buckley CM; Ovsiew GP; Jennette KJ; Resch ZJ; Basurto KS; Song W; Pliskin NH; Soble JR
    Appl Neuropsychol Adult; 2022 Jan; ():1-10. PubMed ID: 34985401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean response latency indices on the Victoria Symptom Validity Test do not contribute meaningful predictive value over accuracy scores for detecting invalid performance.
    Cerny BM; Rhoads T; Leib SI; Jennette KJ; Basurto KS; Durkin NM; Ovsiew GP; Resch ZJ; Soble JR
    Appl Neuropsychol Adult; 2022; 29(6):1304-1311. PubMed ID: 33470869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Victoria Symptom Validity Test: A Systematic Review and Cross-Validation Study.
    Resch ZJ; Webber TA; Bernstein MT; Rhoads T; Ovsiew GP; Soble JR
    Neuropsychol Rev; 2021 Jun; 31(2):331-348. PubMed ID: 33433828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Working Memory, Processing Speed, and Memory Functioning Are Minimally Predictive of Victoria Symptom Validity Test Performance.
    Resch ZJ; Soble JR; Ovsiew GP; Castillo LR; Saladino KF; DeDios-Stern S; Schulze ET; Song W; Pliskin NH
    Assessment; 2021 Sep; 28(6):1614-1623. PubMed ID: 32174137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of various WAIS-IV Digit Span indices for identifying noncredible performance validity among cognitively impaired and unimpaired examinees.
    Webber TA; Soble JR
    Clin Neuropsychol; 2018 May; 32(4):657-670. PubMed ID: 29256334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not so fast! Limitations of processing speed and working memory indices as embedded performance validity tests in a mixed neuropsychiatric sample.
    Ovsiew GP; Resch ZJ; Nayar K; Williams CP; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):473-484. PubMed ID: 32498648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of processing speed and memory performance on classification accuracy of the dot counting test in a mixed neuropsychiatric sample.
    Phillips MS; Wisinger AM; Cerny BM; Khan H; Chang F; Tse KYP; Ovsiew GP; Resch ZJ; Shapiro G; Soble JR; Jennette KJ
    J Clin Exp Neuropsychol; 2024 Jun; ():1-13. PubMed ID: 38847827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Psychometric Properties of Eight Embedded Performance Validity Tests in the Rey Auditory Verbal Learning Test, Wechsler Memory Scale Logical Memory, and Brief Visuospatial Memory Test-Revised Recognition Trials for Detecting Invalid Neuropsychological Test Performance.
    Pliskin JI; DeDios Stern S; Resch ZJ; Saladino KF; Ovsiew GP; Carter DA; Soble JR
    Assessment; 2021 Dec; 28(8):1871-1881. PubMed ID: 32484371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining Traditional and Novel Validity Indicators from the Medical Symptom Validity Test Across Levels of Verbal and Visual Memory Impairment.
    Cerny BM; Resch ZJ; Rhoads T; Jennette KJ; Singh PG; Ovsiew GP; Soble JR
    Arch Clin Neuropsychol; 2022 Jan; 37(1):146-159. PubMed ID: 34050349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Direct Comparison of 10 WAIS-IV Digit Span Embedded Validity Indicators among a Mixed Neuropsychiatric Sample with Varying Degrees of Cognitive Impairment.
    Resch ZJ; Cerny BM; Ovsiew GP; Jennette KJ; Bing-Canar H; Rhoads T; Soble JR
    Arch Clin Neuropsychol; 2023 May; 38(4):619-632. PubMed ID: 36244241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Victoria Symptom Validity Test performance in children and adolescents with neurological disorders.
    Brooks BL
    Arch Clin Neuropsychol; 2012 Dec; 27(8):858-68. PubMed ID: 23037621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition.
    Rhoads T; Neale AC; Resch ZJ; Cohen CD; Keezer RD; Cerny BM; Jennette KJ; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):437-448. PubMed ID: 34233580
    [No Abstract]   [Full Text] [Related]  

  • 14. All of the accuracy in half of the time: Assessing abbreviated versions of the Test of Memory Malingering in the context of verbal and visual memory impairment.
    Cohen CD; Rhoads T; Keezer RD; Jennette KJ; Williams CP; Hansen ND; Ovsiew GP; Resch ZJ; Soble JR
    Clin Neuropsychol; 2022 Oct; 36(7):1933-1949. PubMed ID: 33836622
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationships among victoria symptom validity test indices and personality assessment inventory validity scales in a large clinical sample.
    Haggerty KA; Frazier TW; Busch RM; Naugle RI
    Clin Neuropsychol; 2007 Dec; 21(6):917-28. PubMed ID: 17886150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working memory and intelligence are associated with victoria symptom validity test hard item performance in patients with intractable epilepsy.
    Keary TA; Frazier TW; Belzile CJ; Chapin JS; Naugle RI; Najm IM; Busch RM
    J Int Neuropsychol Soc; 2013 Mar; 19(3):314-23. PubMed ID: 23331934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Victoria symptom validity test performance in non-litigating epilepsy surgery candidates.
    Loring DW; Lee GP; Meador KJ
    J Clin Exp Neuropsychol; 2005 Jul; 27(5):610-7. PubMed ID: 16019637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariable analysis of the relative utility and additive value of eight embedded performance validity tests for classifying invalid neuropsychological test performance.
    Jennette KJ; Rhoads T; Resch ZJ; Cerny BM; Leib SI; Sharp DW; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2022 Sep; 44(7):451-460. PubMed ID: 36197342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired or invalid? Limitations of assessing performance validity using the Boston Naming Test.
    Abramson DA; Resch ZJ; Ovsiew GP; White DJ; Bernstein MT; Basurto KS; Soble JR
    Appl Neuropsychol Adult; 2022; 29(4):486-491. PubMed ID: 32538174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining independent and combined accuracy of embedded performance validity tests in the California Verbal Learning Test-II and Brief Visuospatial Memory Test-Revised for detecting invalid performance.
    Resch ZJ; Pham AT; Abramson DA; White DJ; DeDios-Stern S; Ovsiew GP; Castillo LR; Soble JR
    Appl Neuropsychol Adult; 2022; 29(2):252-261. PubMed ID: 32202916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.